Prevalence of Metabolic Syndrome in Heart Transplant Patients: Role of Previous Cardiopathy and Years Since the Procedure-the TRACA Study

Journal of Heart and Lung Transplantation

Volumn 25, Issue 10, 2006, Pages 1192-1198

  Cordero Fort, Alberto ^a   Gavira, Juan José ^a   Alegría Barrero, Eduardo ^a   Castaño, Sara ^a   Martín, Ana ^a   Ubilla, Matías ^a   Mastrobuoni, Stefano ^a   Alegría Ezquerra, Eduardo ^a   Herreros, Jesús ^a   Rábago, Gregorio ^a  

^a UNIVERSITY CLINIC OF NAVARRA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; BLOOD PRESSURE; BODY MASS; CHOLESTEROL BLOOD LEVEL; CONFIDENCE INTERVAL; DIABETES MELLITUS; DISEASE SEVERITY; FEMALE; GLOMERULUS FILTRATION RATE; HEART GRAFT; HUMAN; ISCHEMIC HEART DISEASE; KIDNEY DYSFUNCTION; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; OBESITY; PREVALENCE; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE;

AGED; FEMALE; HEART TRANSPLANTATION; HUMANS; INTRA-ABDOMINAL FAT; KIDNEY DISEASES; MALE; METABOLIC SYNDROME X; MIDDLE AGED; MULTIVARIATE ANALYSIS; MYOCARDIAL ISCHEMIA; OBESITY; POSTOPERATIVE COMPLICATIONS; PREVALENCE; SEVERITY OF ILLNESS INDEX; TIME FACTORS;

EID: 33749526844     PISSN: 10532498     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.healun.2006.06.012     Document Type: Article

References (33)

1. Yusuf S., Hawken S., Ounpuu S., et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet 364 (2004) 937-952
2. Bibbins-Domingo K., Lin F., Vittinghoff E., et al. Predictors of heart failure among women with coronary disease. Circulation 110 (2004) 1424-1430
3. Taylor D.O., Edwards L.B., Boucek M.M., et al. Registry of the International Society for Heart and Lung Transplantation: twenty-second official adult heart transplant report-2005. J Heart Lung Transplant 24 (2005) 945-955
4. Almenar L., and Spanish Heart Transplantation Registry. 16th official report of the Spanish Society of Cardiology working group on heart failure, heart transplantation, and associated therapies. Rev Esp Cardiol 58 (2005) 1310-1317
5. Reaven G.M. Banting lecture 1988. Role of insulin resistance in human disease. Diabetes 37 (1988) 1595-1607
6. Eckel R.H., Grundy S.M., and Zimmet P.Z. The metabolic syndrome. Lancet 365 (2005) 1415-1428
7. Ninomiya J.K., L'Italien G., Criqui M.H., Whyte J.L., Gamst A., and Chen R.S. Association of the metabolic syndrome with history of myocardial infarction and stroke in the Third National Health and Nutrition Examination Survey. Circulation 109 (2004) 42-46
8. Chen J., Muntner P., Hamm L.L., et al. The metabolic syndrome and chronic kidney disease in U.S. adults. Ann Intern Med 140 (2004) 167-174
9. Corsetti J.P., Zareba W., Moss A.J., et al. Metabolic syndrome best defines the multivariate distribution of blood variables in postinfarction patients. Atherosclerosis 171 (2003) 351-358
10. Winters G.L., Kendall T.J., Radio S.J., et al. Posttransplant obesity and hyperlipidemia: major predictors of severity of coronary arteriopathy in failed human heart allografts. J Heart Transplant 9 (1990) 364-371
11. Haddad M., Pflugfelder P.W., Guiraudon C., et al. Angiographic, pathologic, and clinical relationships in coronary artery disease in cardiac allografts. J Heart Lung Transplant 24 (2005) 1218-1225
12. Valantine H., Rickenbacker P., Kemna M., et al. Metabolic abnormalities characteristic of dysmetabolic syndrome predict the development of transplant coronary artery disease: a prospective study. Circulation 103 (2001) 2144-2152
13. Senechal M., Lemieux I., Beucler I., et al. Features of the metabolic syndrome of "hypertriglyceridemic waist" and transplant coronary artery disease. J Heart Lung Transplant 24 (2005) 819-826
14. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 39 suppl (2002) S1-S266
15. Cordero A., Laclaustra M., Leon M., et al. Cardiovascular risk factors and metabolic syndrome associated with subclinical renal failure. Med Clin (Barc) 125 (2005) 653-658
16. Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 285 (2001) 2486-2497
17. Libby P. Inflammation in atherosclerosis. Nature 420 (2002) 868-874
18. Kobashigawa J.A., Katznelson S., Laks H., et al. Effect of pravastatin on outcomes after cardiac transplantation. N Engl J Med 333 (1995) 621-627
19. Flegal K.M., Carroll M.D., Ogden C.L., and Johnson C.L. Prevalence and trends in obesity among US adults, 1999-2000. JAMA 288 (2002) 1723-1727
20. Levantesi G., Macchia A., Marfisi R., et al. Metabolic syndrome and risk of cardiovascular events after myocardial infarction. JAMA 46 (2005) 277-283
21. Bursi F., Enriquez-Sarano M., Nkomo V.T., et al. Heart failure and death after myocardial infarction in the community: the emerging role of mitral regurgitation. Circulation 111 (2005) 295-301
22. Alegria E., Cordero A., Laclaustra M., et al., MESYAS registry. Prevalence of metabolic syndrome in the Spanish working population. Rev Esp Cardiol 58 (2005) 797-806
23. Nieves D.J., Cnop M., Retzlaff B., et al. The atherogenic lipoprotein profile associated with obesity and insulin resistance is largely attributable to intra-abdominal fat. Diabetes 52 (2003) 172-179
24. Yusuf S., Hawken S., Ounpuu S., et al. Obesity and the risk of myocardial infarction in 27,000 participants from 52 countries: a case-control study. Lancet 366 (2005) 1640-1649
25. Lamarche B., Tchernof A., Mauriege P., et al. Fasting insulin and apolipoprotein B levels and low-density lipoprotein particle size as risk factors for ischemic heart disease. JAMA 279 (1998) 1955-1961
26. McLaughlin T., Abbasi F., Cheal K., Chu J., Lamendola C., and Reaven G. Use of metabolic markers to identify overweight individuals who are insulin resistant. Ann Intern Med 139 (2003) 802-809
27. Kapadia S.R., Nissen S.E., Ziada K.M., et al. Impact of lipid abnormalities in development and progression of transplant coronary disease: a serial intravascular ultrasound study. JAMA 38 (2001) 206-213
28. Lietz K., John R., Burke E.A., et al. Pretransplant cachexia and morbid obesity are predictors of increased mortality after heart transplantation. Transplantation 72 (2001) 277-283
29. Grady K.L., Naftel D., Pamboukian S.V., et al. Post-operative obesity and cachexia are risk factors for morbidity and mortality after heart transplant: multi-institutional study of post-operative weight change. J Heart Lung Transplant 24 (2005) 1424-1430
30. Alberti K.G., Zimmet P., and Shaw J. The metabolic syndrome-a new worldwide definition. Lancet 366 (2005) 1059-1062
31. Bacal F., Moreira L., Souza G., Rodrigues A.C., Fiorelli A., Stolf N., et al. Dobutamine stress echocardiography predicts cardiac events or death in asymptomatic patients long-term after heart transplantation: 4-year prospective evaluation. J Heart Lung Transplant 23 (2004) 1238-1244
32. Ojo A.O., Held P.J., Port F.K., et al. Chronic renal failure after transplantation of a nonrenal organ. N Engl J Med 349 (2003) 931-940
33. Garrido I.P., Crespo-Leiro M.G., Paniagua M.J., et al. Independent predictors of renal dysfunction after heart transplantation in patients with normal pretransplant renal function. J Heart Lung Transplant 24 (2005) 1226-1230